U. Assogba

401 total citations
23 papers, 192 citations indexed

About

U. Assogba is a scholar working on Surgery, Biochemistry and Epidemiology. According to data from OpenAlex, U. Assogba has authored 23 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Biochemistry and 3 papers in Epidemiology. Recurrent topics in U. Assogba's work include Lipoproteins and Cardiovascular Health (5 papers), Antioxidant Activity and Oxidative Stress (3 papers) and HIV/AIDS Research and Interventions (2 papers). U. Assogba is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Antioxidant Activity and Oxidative Stress (3 papers) and HIV/AIDS Research and Interventions (2 papers). U. Assogba collaborates with scholars based in France, United States and Sweden. U. Assogba's co-authors include Éric Bruckert, Dominique Bonnefont‐Rousselot, Sylvie Lepage, Gilbert Deray, Pierre Hausfater, J.C. Piette, Pierre Lebon, J Delattre, P. Cacoub and Lucile Mercadal and has published in prestigious journals such as The Lancet, Clinica Chimica Acta and Clinical Journal of the American Society of Nephrology.

In The Last Decade

U. Assogba

23 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Assogba France	9	49	42	31	27	25	23	192
Kenji So Australia	8	57 1.2×	24 0.6×	65 2.1×	8 0.3×	9 0.4×	22	183
Jeremy Schwieger United States	7	133 2.7×	87 2.1×	27 0.9×	7 0.3×	42 1.7×	8	356
Lawrence S. Milner United States	9	25 0.5×	84 2.0×	18 0.6×	11 0.4×	6 0.2×	23	237
Hiroya Takeoka Japan	8	29 0.6×	54 1.3×	12 0.4×	5 0.2×	13 0.5×	28	193
Juliana Caires de Oliveira Achili Ferreira Brazil	8	20 0.4×	88 2.1×	29 0.9×	14 0.5×	12 0.5×	22	225
Ilona Nowak Poland	6	20 0.4×	36 0.9×	18 0.6×	6 0.2×	18 0.7×	14	193
Koyal Jain United States	7	16 0.3×	44 1.0×	36 1.2×	19 0.7×	7 0.3×	23	177
Abdullah Şumnu Türkiye	8	48 1.0×	101 2.4×	38 1.2×	18 0.7×	25 1.0×	36	231
Misao Niwa Japan	5	80 1.6×	44 1.0×	14 0.5×	13 0.5×	6 0.2×	5	240
Roxana Bologa United States	5	186 3.8×	75 1.8×	60 1.9×	25 0.9×	8 0.3×	10	375

Countries citing papers authored by U. Assogba

Since Specialization

Citations

This map shows the geographic impact of U. Assogba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Assogba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Assogba more than expected).

Fields of papers citing papers by U. Assogba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Assogba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Assogba. The network helps show where U. Assogba may publish in the future.

Co-authorship network of co-authors of U. Assogba

This figure shows the co-authorship network connecting the top 25 collaborators of U. Assogba. A scholar is included among the top collaborators of U. Assogba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Assogba. U. Assogba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercadal, Lucile, Sophie Tézenas du Montcel, Michel B. Chonchol, et al.. (2018). Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial. American Journal of Nephrology. 48(5). 349–356. 3 indexed citations

Mercadal, Lucile, Mathieu Coudert, Anne Vassault, et al.. (2012). L-Carnitine Treatment in Incident Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 7(11). 1836–1842. 26 indexed citations

Vassilief, D., et al.. (2004). Evaluation of the impact of information about treatment‐related risks in patients receiving blood‐derived or recombinant medications. Haemophilia. 10(5). 572–581. 5 indexed citations

Hausfater, Pierre, P. Cacoub, U. Assogba, Pierre Lebon, & J.C. Piette. (2002). Plasma Exchange and Interferon-Alpha Pharmacokinetics in Patients with Hepatitis C Virus-Associated Systemic Vasculitis. The Nephron journals/Nephron journals. 91(4). 627–630. 23 indexed citations

Mercadal, Lucile, Thierry Petitclerc, U. Assogba, H Beaufils, & Gilbert Deray. (2000). Hemolytic and Uremic Syndrome after Heart Transplantation. American Journal of Nephrology. 20(5). 418–420. 10 indexed citations

Cacoub, P., Anne‐Claude Camproux, U. Assogba, et al.. (2000). A new approach for rapid detection and typing of serum monoclonal components. Clinica Chimica Acta. 302(1-2). 105–124. 1 indexed citations

Lepage, Sylvie, Fabienne Nigon, Dominique Bonnefont‐Rousselot, et al.. (2000). Oxidizability of Atherogenic Low-Density Lipoprotein Subspecies in Severe Familial Hypercholesterolemia: Impact of Long-Term Low-Density Lipoprotein Apheresis. Journal of Cardiovascular Pharmacology and Therapeutics. 5(2). 87–103. 10 indexed citations

Lepage, Sylvie, et al.. (1996). Antioxidant status of hypercholesterolemic patients treated with LDL apheresis. Cardiovascular Drugs and Therapy. 10(5). 567–571. 8 indexed citations

Assogba, U., Sylvie Lepage, Éric Bruckert, et al.. (1995). Blood antioxidants (vitamin E and β-carotene) in long-term low density lipoprotein apheresis. Clinica Chimica Acta. 235(2). 147–157. 17 indexed citations

10.

Bonnefont‐Rousselot, Dominique, U. Assogba, Éric Bruckert, et al.. (1995). Preferential depletion of selenoprotein P in hypercholesterolaemic patients treated by LDL-apheresis. Clinica Chimica Acta. 240(2). 209–212. 9 indexed citations

11.

Corpechot, Christophe, U. Assogba, Beaumont Jl, et al.. (1994). [Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases].. PubMed. 18(8-9). 743–50. 5 indexed citations

12.

Assogba, U., et al.. (1994). [Biological efficacy of LDL apheresis in major hypercholesterolemia].. PubMed. 145(5). 328–32. 3 indexed citations

13.

Cacoub, P., L. Musset, Frans M. Verduyn Lunel, et al.. (1993). Analyse en western blot des cryoglobulines associées aux hépatites chroniques C. La Revue de Médecine Interne. 14(10). 1007–1007. 2 indexed citations

14.

Bellin, Marie‐France, et al.. (1992). GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure. Magnetic Resonance Imaging. 10(1). 115–118. 34 indexed citations

15.

Rottembourg, J, et al.. (1988). Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.. PubMed. 23. 152–9. 6 indexed citations

16.

Assogba, U., et al.. (1988). Prospective study of HIV I seropositive patients in hemodialysis centers.. PubMed. 29(6). 312–4. 8 indexed citations

17.

Assogba, U., et al.. (1988). [HIV1 infections in dialysis centers. Prospective studies in 4 centers in Ile-de-France].. PubMed. 9(3). 139–41. 1 indexed citations

18.

Rottembourg, J, et al.. (1988). [Comparison between treatments of severe forms of familial hypercholesterolemia by total plasma exchange and selective removal of low density lipoproteins (LDLapheresis)].. PubMed. 17(33). 1679–82. 3 indexed citations

19.

Deray, Gilbert, et al.. (1987). Oral contraceptive interaction with cyclosporin [letter]. The Lancet. 1(8525). 3 indexed citations

20.

Klatzmann, David, Gluckman Jc, C. Foucault, et al.. (1983). The influence of blood transfusions on lymphocyte reactivity in man.. PubMed. 19. 453–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact